Nora Chiang

1.6k total citations
21 papers, 1.1k citations indexed

About

Nora Chiang is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Toxicology. According to data from OpenAlex, Nora Chiang has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 7 papers in Pharmacology and 6 papers in Toxicology. Recurrent topics in Nora Chiang's work include Neurotransmitter Receptor Influence on Behavior (13 papers), Forensic Toxicology and Drug Analysis (6 papers) and Cannabis and Cannabinoid Research (3 papers). Nora Chiang is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (13 papers), Forensic Toxicology and Drug Analysis (6 papers) and Cannabis and Cannabinoid Research (3 papers). Nora Chiang collaborates with scholars based in United States, Australia and Switzerland. Nora Chiang's co-authors include Ahmed Elkashef, Roberta Kahn, John D. Roache, Tyson H. Holmes, A. Anderson, Thomas F. Newton, Frank J. Vocci, Richard De La Garza, Christopher L. Wallace and Shou-Hua Li and has published in prestigious journals such as Neuropsychopharmacology, Psychopharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Nora Chiang

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nora Chiang United States 16 676 306 223 210 197 21 1.1k
Roberta Kahn United States 15 682 1.0× 282 0.9× 246 1.1× 234 1.1× 200 1.0× 22 1.0k
Peter Jatlow United States 18 482 0.7× 246 0.8× 300 1.3× 202 1.0× 273 1.4× 25 1.3k
Keith G. Heinzerling United States 25 710 1.1× 347 1.1× 223 1.0× 253 1.2× 544 2.8× 55 1.7k
Thomas R. Kosten United States 15 482 0.7× 194 0.6× 202 0.9× 112 0.5× 253 1.3× 16 910
Ofra Sarid‐Segal United States 19 601 0.9× 217 0.7× 177 0.8× 320 1.5× 306 1.6× 27 1.3k
Thorne Sparkman United States 12 471 0.7× 193 0.6× 147 0.7× 204 1.0× 247 1.3× 15 802
Susan J. Boyd United States 15 343 0.5× 400 1.3× 154 0.7× 77 0.4× 222 1.1× 21 968
Debra Harris United States 17 323 0.5× 261 0.9× 107 0.5× 285 1.4× 118 0.6× 24 1.2k
Susan M. Learned United States 15 259 0.4× 255 0.8× 175 0.8× 219 1.0× 148 0.8× 22 1.1k
R R Griffiths United States 19 395 0.6× 405 1.3× 239 1.1× 134 0.6× 78 0.4× 26 1.3k

Countries citing papers authored by Nora Chiang

Since Specialization
Citations

This map shows the geographic impact of Nora Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Chiang more than expected).

Fields of papers citing papers by Nora Chiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Chiang. The network helps show where Nora Chiang may publish in the future.

Co-authorship network of co-authors of Nora Chiang

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Chiang. A scholar is included among the top collaborators of Nora Chiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Chiang. Nora Chiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiang, Nora, et al.. (2019). Successful treatment of Stiff Person Syndrome with intrathecal baclofen. PubMed. 2(1). 1000016–1000016. 1 indexed citations
2.
Elkashef, Ahmed, James Robert Brašić, Roberta Kahn, et al.. (2018). A cholecystokinin B receptor antagonist and cocaine interaction, phase I study. CNS Neuroscience & Therapeutics. 25(1). 136–146. 6 indexed citations
3.
Gilgun‐Sherki, Yossi, Rom E. Eliaz, David J. McCann, et al.. (2016). Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence. Drug and Alcohol Dependence. 166. 13–20. 32 indexed citations
4.
Krieter, Philip A., et al.. (2016). Pharmacokinetic Properties and Human Use Characteristics of an FDA‐Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose. The Journal of Clinical Pharmacology. 56(10). 1243–1253. 80 indexed citations
5.
Anderson, A., Denka Markova, Tyson H. Holmes, et al.. (2015). Bupropion for the treatment of methamphetamine dependence in non-daily users: A randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence. 150. 170–174. 49 indexed citations
6.
Anderson, A., Shou-Hua Li, Kousick Biswas, et al.. (2011). Modafinil for the treatment of methamphetamine dependence. Drug and Alcohol Dependence. 120(1-3). 135–141. 82 indexed citations
7.
Anderson, A., Malcolm S. Reid, Tyson H. Holmes, et al.. (2009). Modafinil for the treatment of cocaine dependence. Drug and Alcohol Dependence. 104(1-2). 133–139. 175 indexed citations
8.
Kahn, Roberta, Kousick Biswas, Steven Shoptaw, et al.. (2009). Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug and Alcohol Dependence. 103(1-2). 59–64. 56 indexed citations
9.
10.
Elkashef, Ahmed, Richard A. Rawson, A. Anderson, et al.. (2007). Bupropion for the Treatment of Methamphetamine Dependence. Neuropsychopharmacology. 33(5). 1162–1170. 169 indexed citations
11.
Elkashef, Ahmed, Paul J. Fudala, Shou-Hua Li, et al.. (2006). Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence. Drug and Alcohol Dependence. 85(3). 191–197. 40 indexed citations
12.
Newton, Thomas F., John D. Roache, Richard De La Garza, et al.. (2005). Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology. 182(3). 426–435. 49 indexed citations
13.
Newton, Thomas F., John D. Roache, Richard De La Garza, et al.. (2005). Bupropion Reduces Methamphetamine-Induced Subjective Effects and Cue-Induced Craving. Neuropsychopharmacology. 31(7). 1537–1544. 131 indexed citations
14.
Newton, Thomas F., Richard De La Garza, Nora Chiang, et al.. (2005). A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline. Pharmacology Biochemistry and Behavior. 82(4). 704–711. 22 indexed citations
15.
Compton, Peggy, Walter Ling, David E. Moody, & Nora Chiang. (2005). Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine. Drug and Alcohol Dependence. 82(1). 25–31. 37 indexed citations
16.
Houtsmuller, Elisabeth J., et al.. (2003). Transdermal selegiline and intravenous cocaine: safety and interactions. Psychopharmacology. 172(1). 31–40. 24 indexed citations
17.
Mendelson, John, Naoto Uemura, Laeben Lester, et al.. (2001). Pharmacologic interactions between transdermal selegiline and cocaine. Clinical Pharmacology & Therapeutics. 69(2). 1 indexed citations
18.
Chiang, Nora, et al.. (2001). The Overseas Chinese in Australasia: History, Settlement, and Interactions. 15 indexed citations
19.
Chiang, Nora, et al.. (1997). Is quantitative urinalysis more sensitive?. PubMed. 175. 265–86. 4 indexed citations
20.
Leeson, Lewis J., et al.. (1985). Thein vitro development of extended-release solid oral dosage forms. Journal of Pharmacokinetics and Biopharmaceutics. 13(5). 493–514. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta Kahn Breakdown of academic impact, for papers by Peter Jatlow Breakdown of academic impact, for papers by Keith G. Heinzerling Breakdown of academic impact, for papers by Thomas R. Kosten Breakdown of academic impact, for papers by Ofra Sarid‐Segal Breakdown of academic impact, for papers by Thorne Sparkman Breakdown of academic impact, for papers by Susan J. Boyd Breakdown of academic impact, for papers by Debra Harris Breakdown of academic impact, for papers by Susan M. Learned Breakdown of academic impact, for papers by R R Griffiths
Rankless by CCL
2026